Arkolith/Insider Trading/RNTX/Form 4

Voss Value Master Fund, LP

10% OwnerRein Therapeutics, Inc. (RNTX) · full profile →Form 4 · filed Nov 18, 2025
Net Buying
Open-Market Buys
$127K
Open-Market Sells
$0
Net Open-Market Flow
$127K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2025Buy(P)104K$1.22$127K926K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-003156) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML